Compare UNCY & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNCY | LNZA |
|---|---|---|
| Founded | 2016 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 114.8M |
| IPO Year | 2021 | N/A |
| Metric | UNCY | LNZA |
|---|---|---|
| Price | $6.21 | $10.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $44.50 | $14.00 |
| AVG Volume (30 Days) | ★ 700.0K | 10.0K |
| Earning Date | 11-12-2025 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,876,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $113.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.71 | $9.74 |
| 52 Week High | $11.00 | $107.00 |
| Indicator | UNCY | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 51.23 | 26.70 |
| Support Level | $6.12 | $11.42 |
| Resistance Level | $6.94 | $12.96 |
| Average True Range (ATR) | 0.52 | 0.99 |
| MACD | -0.06 | -0.29 |
| Stochastic Oscillator | 45.21 | 4.72 |
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
LanzaTech Global Inc is a carbon management company transforming waste carbon into sustainable fuels, fabrics, packaging, and nutrition. Its goal is to advance a circular economy where carbon is reused rather than wasted, reducing reliance on virgin fossil resources and supporting supply chain resilience. The company operates in North America, Europe, Middle East, Africa (EMEA), Asia, and Australia.